Form 4: Director Cheryl Pegus Increases Stake in Boston Scientific

Boston Scientific Director Cheryl Pegus purchased 1,770 shares of common stock at an average price of $56.49.

Summary

• Director Cheryl Pegus acquired 1,770 shares of Boston Scientific Corporation (BSX) common stock.
• The transaction occurred on May 20, 2026.
• The shares were purchased at a weighted average price of $56.49 per share, with individual transaction prices ranging from $56.49 to $56.5009.
• Following this transaction, the reporting person holds 1,770 shares directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, as it reflects direct financial commitment from a member of the board of directors.

Positives

• Insider confidence is demonstrated by a director purchasing shares with personal capital.

Negatives

• None identified.

Risks

• Market volatility affecting the value of the acquired equity.

Future Outlook

Not applicable as this is a routine insider transaction report.

Industry Context

StockSavvy.ai notes that director-level insider buying is generally viewed as a positive signal of long-term confidence in the company's strategic direction within the medical device sector.

Comparison to Industry Standards

• Insider purchases by board members are standard corporate governance activities and align with typical market behavior for large-cap healthcare companies.

Stakeholder Impact

• Shareholders may view this as a sign of internal confidence in the company's valuation.

Next Steps

• No further actions required by the reporting person regarding this specific transaction.

Key Dates

Keywords

Boston Scientific, BSX, Insider Trading, Form 4, Director Purchase, Equity Ownership